BioCentury | Oct 17, 2020
Emerging Company Profile

Fed Bio: designing gut microbiomes with staying power and enhancing immune-modulating bacteria

...the Stanford Microbiome Therapies Initiative and co-founder of Revolution Medicines Inc....
BioCentury | Aug 11, 2020
Emerging Company Profile

Through LianBio, Perceptive forms bridge for Western pipeline into Asia

...tumor indications: JAB-3068 and JAB-3312 from Beijing Jacobio Pharmaceutical Co. Ltd.; RMC-4630 from Sanofi (Euronext:SAN; NASDAQ:SNY) and Revolution Medicines Inc....
BioCentury | Jun 6, 2020
Finance

Daily Chart: NASDAQ’s dazzling debuts

...Inc Pliant Therapeutics Inc. Ayala Pharmaceuticals Inc. Lyra Therapeutics Inc. ORIC Pharmaceuticals Inc. Keros Therapeutics Inc. Zentalis Pharmaceuticals Inc. Imara Inc. Passage Bio Inc. Revolution Medicines Inc. Beam...
BioCentury | Jun 2, 2020
Product Development

Sanofi makes case for why its first cancer drug in a decade can take on Darzalex

...the next 18 months including a SHP-2 inhibitor brought in through a 2018 deal with Revolution Medicines Inc....
BioCentury | Feb 14, 2020
Finance

You say you want a Revolution? Oncology company is latest to post big gain after IPO

...investors’ demand for the cancer company’s shares rose both before and after its offering priced. Revolution Medicines Inc....
...held 21.7% of Revolution’s shares after the pricing. Third Rock had invested $31 million across Revolution Medicines’...
...the seven companies to list on NASDAQ this year via offerings larger than $25 million, Revolution Medicines’...
BioCentury | Feb 1, 2020
Finance

Arcutis gains in this year’s third biotherapeutic IPO on NASDAQ

...other biotechs are aiming to price NASDAQ IPOs in the coming weeks, including cancer company Revolution Medicines Inc....
BioCentury | Jan 29, 2020
Company News

Decibel narrows discovery focus to inner ear regeneration, taps Reid as CEO

...Rock, Reid was CEO of Warp Drive Bio Inc., which the firm launched in 2012. Revolution Medicines Inc....
BioCentury | Jan 23, 2020
Financial News

Jan. 22 Financial Quick Takes: Genmab-J&J, Adaptimmune, Revolution, PDC*line

...Therapies” ). Revolution proposes NASDAQ listing After raising $100 million in a July series C, Revolution Medicines Inc....
...homology protein tyrosine phosphatase 2; mTOR (FRAP; RAFT1) - Mammalian target of rapamycin Hongjiang Li, Staff Writer Revolution Medicines Inc. Genmab...
BioCentury | Jan 22, 2020
Emerging Company Profile

Relay’s protein motion platform approaches clinical starting line

...that change a target’s shape. Other companies seeking to drug allosteric sites on proteins include Revolution Medicines Inc....
BioCentury | Nov 5, 2019
Company News

Nov. 4 Company Quick Takes: FDA approves RedHill’s antibiotic; plus NiKang, Revolution-Amgen, Aveo and Tmunity-Oncora

...KRAS program Amgen Inc. (NASDAQ:AMGN) will test its KRAS inhibitor AMG 510 in combination with Revolution Medicines Inc.’s...
...Eaton, Staff Writer Talicia (RHB-105, heliconda) AMG 510 Fotivda, tivozanib (ASP4130, AV-951, krn951) RedHill Biopharma Ltd. Turning Point Therapeutics Inc. Amgen Inc. Revolution Medicines Inc. Aveo...
Items per page:
1 - 10 of 37
BioCentury | Oct 17, 2020
Emerging Company Profile

Fed Bio: designing gut microbiomes with staying power and enhancing immune-modulating bacteria

...the Stanford Microbiome Therapies Initiative and co-founder of Revolution Medicines Inc....
BioCentury | Aug 11, 2020
Emerging Company Profile

Through LianBio, Perceptive forms bridge for Western pipeline into Asia

...tumor indications: JAB-3068 and JAB-3312 from Beijing Jacobio Pharmaceutical Co. Ltd.; RMC-4630 from Sanofi (Euronext:SAN; NASDAQ:SNY) and Revolution Medicines Inc....
BioCentury | Jun 6, 2020
Finance

Daily Chart: NASDAQ’s dazzling debuts

...Inc Pliant Therapeutics Inc. Ayala Pharmaceuticals Inc. Lyra Therapeutics Inc. ORIC Pharmaceuticals Inc. Keros Therapeutics Inc. Zentalis Pharmaceuticals Inc. Imara Inc. Passage Bio Inc. Revolution Medicines Inc. Beam...
BioCentury | Jun 2, 2020
Product Development

Sanofi makes case for why its first cancer drug in a decade can take on Darzalex

...the next 18 months including a SHP-2 inhibitor brought in through a 2018 deal with Revolution Medicines Inc....
BioCentury | Feb 14, 2020
Finance

You say you want a Revolution? Oncology company is latest to post big gain after IPO

...investors’ demand for the cancer company’s shares rose both before and after its offering priced. Revolution Medicines Inc....
...held 21.7% of Revolution’s shares after the pricing. Third Rock had invested $31 million across Revolution Medicines’...
...the seven companies to list on NASDAQ this year via offerings larger than $25 million, Revolution Medicines’...
BioCentury | Feb 1, 2020
Finance

Arcutis gains in this year’s third biotherapeutic IPO on NASDAQ

...other biotechs are aiming to price NASDAQ IPOs in the coming weeks, including cancer company Revolution Medicines Inc....
BioCentury | Jan 29, 2020
Company News

Decibel narrows discovery focus to inner ear regeneration, taps Reid as CEO

...Rock, Reid was CEO of Warp Drive Bio Inc., which the firm launched in 2012. Revolution Medicines Inc....
BioCentury | Jan 23, 2020
Financial News

Jan. 22 Financial Quick Takes: Genmab-J&J, Adaptimmune, Revolution, PDC*line

...Therapies” ). Revolution proposes NASDAQ listing After raising $100 million in a July series C, Revolution Medicines Inc....
...homology protein tyrosine phosphatase 2; mTOR (FRAP; RAFT1) - Mammalian target of rapamycin Hongjiang Li, Staff Writer Revolution Medicines Inc. Genmab...
BioCentury | Jan 22, 2020
Emerging Company Profile

Relay’s protein motion platform approaches clinical starting line

...that change a target’s shape. Other companies seeking to drug allosteric sites on proteins include Revolution Medicines Inc....
BioCentury | Nov 5, 2019
Company News

Nov. 4 Company Quick Takes: FDA approves RedHill’s antibiotic; plus NiKang, Revolution-Amgen, Aveo and Tmunity-Oncora

...KRAS program Amgen Inc. (NASDAQ:AMGN) will test its KRAS inhibitor AMG 510 in combination with Revolution Medicines Inc.’s...
...Eaton, Staff Writer Talicia (RHB-105, heliconda) AMG 510 Fotivda, tivozanib (ASP4130, AV-951, krn951) RedHill Biopharma Ltd. Turning Point Therapeutics Inc. Amgen Inc. Revolution Medicines Inc. Aveo...
Items per page:
1 - 10 of 37